SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For November 1, 2021
Commission File Number 001-33463
ASML Holding N.V.
De Run 6501
5504 DR Veldhoven
The Netherlands
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K on paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K on paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT 99.1 TO THIS REPORT ON FORM 6-K IS INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-142254), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-144356), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-147128), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-153277), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-162439), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-170034), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-188938), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-190023), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-192951), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-203390), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-219442) AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-227464) OF ASML HOLDING N.V. AND IN THE OUTSTANDING PROSPECTUSES CONTAINED IN SUCH REGISTRATION STATEMENTS.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ASML HOLDING N.V. (Registrant) | ||||
Date: November 1, 2021 | By: | /s/ Peter T.F.M. Wennink | ||
Peter T.F.M. Wennink | ||||
Chief Executive Officer |
Exhibit 99.1
Jenoptik intends to acquire Berliner Glas Medical and SwissOptic
Veldhoven, The Netherlands, October 19, 2021 - Jenoptik AG is set to acquire from Berliner Glas GmbH, a 100 percent subsidiary of ASML Holding N.V., a 100 percent stake in the following companies:
| BG Medical Applications GmbH (Berliner Glas Medical), a leading supplier of high-precision, custom optical components for the medical technology sector based in Berlin, |
| SwissOptic AG, a specialist in the development and manufacturing of optical components and assemblies, primarily for the medical technology, semiconductor, and metrology industries headquartered in Heerbrugg/Switzerland, |
| SwissOptic Co., Ltd. (together with SwissOptic AG, SwissOptic), based in Wuhan/China. |
Overall, Berliner Glas Medical and SwissOptic currently employ around 500 people worldwide. The transaction is still subject to approval from the German antitrust authorities. Closing is expected in December 2021.
With this strategic acquisition we will strengthen our global and fast-growing photonics business thus significantly expanding our already strong semiconductor equipment business, and, in particular, our highly attractive medical technology business, says Stefan Traeger, President & CEO of Jenoptik AG.
We are pleased to have reached this agreement whereby Jenoptik will acquire the Medical Applications and SwissOptic business of Berliner Glas (part of ASML), says Andreas Nitze, CEO of the Berliner Glas Group. We are convinced that the combined businesses are well positioned to realize the potential we see for the business and will offer the best environment for its employees.
About ASML
ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanitys toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across Europe, the US and Asia. Every day, ASMLs more than 29,300 employees challenge the status quo and push technology to new limits. ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. Discover ASML our products, technology and career opportunities at www.asml.com.
Contact information
Monique Mols Head of Media Relations +31 652 844 418 |
Iris Teichmann Berliner Glas, marketing & communications +49 30 60905-4950 |